Logo

Navigation

acep now podcast header

By | on April 19, 2022 | 0 Comment
Shutterstock.com

In this month’s episode of ACEP Nowcast, Dr. Cedric Dark speaks with Dr. Anand Swaminathan about his article in the April issue updating readers on current COVID-19 therapeutics, from monoclonal antibodies to Regeneron and everything in-between. 

Topics:

Related

Current Issue

ACEP Now: December 2025 (Digital)

Read More

About the Author

Cedric Dark, MD, MPH, FACEP

A graduate of Morehouse College, Cedric Dark, MD, MPH, FACEP earned his medical degree from New York University School of Medicine. He holds a master’s degree from the Mailman School of Public Health at Columbia University. He completed his residency training at George Washington University where he served as chief resident. Currently, Dr. Dark is an associate professor at the Henry J. N. Taub Department of Emergency Medicine at Baylor College of Medicine. Dr. Dark is the 2017 recipient of the Texas Medical Association’s C. Frank Webber Award, a 2019 American College of Emergency Physicians Choosing Wisely Champion, the Emergency Medicine Residents’ Association 2021 Joseph F. Waeckerle Alumni of the Year Award, one of emergency medicine’s Top 45 Under 45, and on Elemental’s List of 50 Experts to Trust in a Pandemic. He is currently on the Board of Directors for Doctors for America and the medical editor-in-chief for ACEP Now, the official voice of emergency medicine. .

View this author's posts »

No Responses to “April 2022: COVID Therapeutics Update”

Leave a Reply

Your email address will not be published. Required fields are marked *


*


Current Issue

ACEP Now: December 2025 (Digital)

Read More

Wiley
Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 2333-2603